• 1. Examination of the hydrogen-bonding networks in small water clusters (n = 2–5, 13, 17) using absolutely localized molecular orbital energy decomposition analysis?
  Erika A. Cobar,Paul R. Horn,Robert G. Bergman,Martin Head-Gordon Phys. Chem. Chem. Phys., 2012,14, 15328-15339
• 2. Emerging 2D hybrid nanomaterials: towards enhanced sensitive and selective conductometric gas sensors at room temperature
  Hanie Hashtroudi,Ian D. R. Mackinnon J. Mater. Chem. C, 2020,8, 13108-13126
• 3. Esterase-responsive polymeric prodrug-based tumor targeting nanoparticles for improved anti-tumor performance against colon cancer?
  Gang Pan,Yi-jie Bao,Jie Xu,Tao Liu,Cheng Liu,Yan-yan Qiu,Xiao-jing Shi,Hui Yu,Ting-ting Jia,Xia Yuan,Ze-ting Yuan,Yi-jun Cao RSC Adv., 2016,6, 42109-42119
• 4. Establishment and implications of a characterization method for magnetic nanoparticle using cell tracking velocimetry and magnetic susceptibility modified solutions
  Huading Zhang,Lee R. Moore,Maciej Zborowski,P. Stephen Williams,Shlomo Margel,Jeffrey J. Chalmers Analyst, 2005,130, 514-527
• 5. Emergence of cationic polyamine dendrimersomes: design, stimuli sensitivity and potential biomedical applications
  Partha Laskar,Christine Dufès Nanoscale Adv., 2021,3, 6007-6026

5-(Benzyloxy)-6-methyl-1H-indole: A Comprehensive Overview

The compound with CAS No. 19500-00-6, commonly referred to as 5-(Benzyloxy)-6-methyl-1H-indole, is a fascinating molecule that has garnered significant attention in the fields of organic chemistry and pharmacology. This compound belongs to the class of indole derivatives, which are known for their diverse biological activities and structural versatility. The indole core of this molecule serves as a scaffold for various functional groups, making it a valuable substrate for further chemical modifications and biological evaluations.

Recent studies have highlighted the potential of 5-(Benzyloxy)-6-methyl-1H-indole in drug discovery, particularly in the development of anti-cancer agents. Researchers have demonstrated that this compound exhibits selective cytotoxicity against various cancer cell lines, suggesting its potential as a lead compound for anti-tumor therapies. The benzyloxy group attached at the 5-position of the indole ring plays a crucial role in modulating the molecule's pharmacokinetic properties, enhancing its bioavailability and stability in vivo.

In addition to its anti-cancer properties, 5-(Benzyloxy)-6-methyl-1H-indole has also shown promise in anti-inflammatory and neuroprotective applications. Preclinical studies have revealed that this compound inhibits key inflammatory pathways, such as COX-2 and NF-kB, making it a potential candidate for treating inflammatory diseases like arthritis and neurodegenerative disorders. The methyl group at the 6-position of the indole ring contributes to the molecule's lipophilicity, which is essential for crossing biological membranes and reaching target sites effectively.

The synthesis of 5-(Benzyloxy)-6-methyl-1H-indole involves a multi-step process that typically begins with the preparation of an indole derivative followed by functionalization at specific positions. Recent advancements in catalytic asymmetric synthesis have enabled the efficient construction of this molecule with high enantioselectivity, paving the way for its use in chiral drug development. The use of environmentally friendly reagents and conditions has also made this synthesis more sustainable, aligning with current green chemistry principles.

From an analytical standpoint, 5-(Benzyloxy)-6-methyl-1H-indole has been extensively characterized using modern spectroscopic techniques such as NMR, IR, and MS. These studies have provided detailed insights into its molecular structure and conformational dynamics, which are critical for understanding its interaction with biological targets. Computational modeling studies have further revealed that this compound exhibits favorable binding affinities towards various protein targets, reinforcing its potential as a therapeutic agent.

Looking ahead, the exploration of 5-(Benzyloxy)-6-methyl-1H-indole is expected to expand into new areas such as photodynamic therapy and radiopharmaceuticals. Its unique electronic properties make it an ideal candidate for light-triggered drug delivery systems, where it can act as a photosensitizer or a carrier for therapeutic payloads. Furthermore, ongoing clinical trials are evaluating its safety and efficacy in human subjects, bringing it closer to becoming an approved medication.

In conclusion, 5-(Benzyloxy)-6-methyl-1H-indole (CAS No. 19500-00-6) stands out as a versatile and promising molecule with applications spanning multiple therapeutic areas. Its structural features, coupled with cutting-edge research advancements, position it as a key player in the development of novel drugs targeting cancer, inflammation, and neurodegenerative diseases. As research continues to unfold, this compound is likely to unlock new possibilities in medicinal chemistry and personalized medicine.

• 1215-59-4(5-Benzyloxyindole)
• 66124-57-0(4,9-dihydro-Pyrano[2,3,4,5-def]carbazole)
• 840537-99-7(4-(Benzyloxy)-6-methyl-1H-indole)
• 920982-66-7(9H-Carbazole, 6-methoxy-2-[(4-methoxyphenyl)methoxy]-)
• 131802-60-3(7-Benzyloxyquinoline)
• 20289-26-3(4-(benzyloxy)-1H-indole)
• 61545-37-7(1H-Indole-6-methanol, 4-(phenylmethoxy)-)
• 15903-94-3(6-Benzyloxyindole)
• 138518-16-8(1H-Indole, 6-methoxy-4-(phenylmethoxy)-)
• 21987-24-6(5-(benzyloxy)-3-methyl-1H-indole)